{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:47:15Z","timestamp":1792057635918,"version":"4.4.0"},"reference-count":24,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2026,5]]},"abstract":"Abstract<\/jats:title>\n \n Objective:<\/jats:title>\n Multidrug-resistant organisms (MDROs) such as carbapenem-resistant Enterobacterales (CRE) are a significant public health threat. Patients colonized with MDROs are at higher risk of severe outcomes and can serve as a source of spread to others. The public health impact of a hypothetical agent that reduces MDRO load (i.e., pathogen reduction), including in the gastrointestinal tract, has not been described.<\/jats:p>\n <\/jats:sec>\n \n Design:<\/jats:title>\n Compartmental models of CRE transmission in healthcare facilities were used to estimate the impact of a hypothetical pathogen reduction agent on CRE bloodstream infections (BSIs) and deaths.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n The agent was assumed to reduce the time to pathogen clearance with effectiveness varying from 25\u2013100% across simulations. Interventions were modeled in acute care hospitals (ACHs), critical access hospitals, long-term acute care hospitals (LTACHs), skilled nursing facilities, and ventilator-capable skilled nursing facilities (vSNFs). Direct effects (among patients who received the agent) and indirect effects (among patients who did not receive the agent) were estimated at the national healthcare network level.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n At baseline without intervention, an estimated 2,086 CRE BSIs and 622 associated deaths occurred annually nationwide. Use of a pathogen reduction agent in LTACHs and vSNFs averted 69\u201375% of CRE BSIs nationally, with greater reductions when expanded to all facility types. Approximately 90% of averted CRE BSIs would have occurred in patients who were not administered the agent.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n An effective pathogen reduction agent might substantially reduce MDRO infections and deaths among patients in U.S. healthcare facilities. New and expanded efforts are needed to accelerate the development of such products.<\/jats:p>\n <\/jats:sec>","DOI":"10.1017\/ice.2025.10335","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:46:50Z","timestamp":1770724010000},"page":"476-482","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Projected impact of a pathogen reduction intervention on carbapenem-resistant Enterobacterales bloodstream infections and deaths in the United States"],"prefix":"10.1017","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-4399","authenticated-orcid":false,"given":"Hannah","family":"Wolford","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8303-7735","authenticated-orcid":false,"given":"Mohammed A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4096-6171","authenticated-orcid":false,"given":"Prabasaj","family":"Paul","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7393-4814","authenticated-orcid":false,"given":"Damon J.A.","family":"Toth","sequence":"additional","affiliation":[{"name":"University of Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rany","family":"Octaria","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Healy","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2332-0747","authenticated-orcid":false,"given":"Kara","family":"Jacobs Slifka","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8163-925X","authenticated-orcid":false,"given":"John A.","family":"Jernigan","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-0528","authenticated-orcid":false,"given":"Alexander","family":"Kallen","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Clifford","family":"McDonald","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Craig","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroya S.","family":"Walters","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-8040","authenticated-orcid":false,"given":"Rachel B.","family":"Slayton","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"S0899823X25103358_ref14","unstructured":"14. United States Census Bureau. National and State Population Estimates 2018, 2018. https:\/\/www.census.gov\/newsroom\/press-kits\/2018\/pop-estimates-national-state.html."},{"key":"S0899823X25103358_ref11","unstructured":"11. Centers for Disease Control and Prevention. Emerging Infections Program (EIP) 2024. https:\/\/www.cdc.gov\/emerging-infections-program\/php\/network-activities\/index.html."},{"key":"S0899823X25103358_ref18","volume-title":"R: A Language and Environment for Statistical Computing","year":"2024"},{"key":"S0899823X25103358_ref8","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/cid\/ciaa1590","article-title":"Economic evaluations of new antibiotics: the high potential value of reducing healthcare transmission through decolonization","volume":"72","author":"Toth","year":"2021","journal-title":"Clin Infect Dis"},{"key":"S0899823X25103358_ref24","unstructured":"24. National Institutes of Health. Creating a Target Product Profile for New Drug Products, 2023. https:\/\/seed.nih.gov\/sites\/default\/files\/2023-12\/Creating-Target-Profile-for-New-Drug-Products.pdf."},{"key":"S0899823X25103358_ref17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1017\/ice.2023.278","article-title":"Regional impact of multidrug-resistant organism prevention bundles implemented by facility type: a modeling study","volume":"45","author":"Cincotta","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"key":"S0899823X25103358_ref7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3201\/eid3006.231338","article-title":"Decolonization and pathogen reduction approaches to prevent antimicrobial resistance and healthcare-associated infections","volume":"30","author":"Mangalea","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"S0899823X25103358_ref2","unstructured":"2. Centers for Disease Control and Prevention. Antimicrobial Resistance Threats in the United States, 2021\u20132022, 2024."},{"key":"S0899823X25103358_ref3","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/cid\/ciy796","article-title":"Increased relative abundance of Klebsiella Pneumoniae carbapenemase-producing Klebsiella Pneumoniae within the gut Microbiota is associated with risk of bloodstream infection in long-term acute care hospital patients","volume":"68","author":"Shimasaki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"S0899823X25103358_ref19","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.jamda.2020.04.007","article-title":"High prevalence of multidrug-resistant organism colonization in\u00a028 nursing homes: an \u201ciceberg effect\u201d","volume":"21","author":"McKinnell","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"S0899823X25103358_ref9","unstructured":"9. Reviews of Modern Physics. Antibiotic Resistance Threats in the United States. Atlanta, GA: U.S. Department of Health and Human Services, 2019."},{"key":"S0899823X25103358_ref22","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1093\/cid\/ciad224","article-title":"Using\u00a0colonization to understand the burden of antimicrobial resistance across low- and middle-income countries","volume":"77","author":"Styczynski","year":"2023","journal-title":"Clin Infect Dis"},{"key":"S0899823X25103358_ref1","doi-asserted-by":"crossref","first-page":"e2462059","DOI":"10.1001\/jamanetworkopen.2024.62059","article-title":"Antimicrobial-resistant infections in hospitalized patients","volume":"8","author":"Wolford","year":"2025","journal-title":"JAMA Network Open"},{"key":"S0899823X25103358_ref23","unstructured":"23. Food and Drug Administration. Drug Development Considerations for the\u00a0Prevention of Healthcare-Associated Infections, 2022. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/drug-development-considerations-prevention-healthcare-associated-infections-08302022."},{"key":"S0899823X25103358_ref6","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.ajic.2007.10.006","article-title":"Healthcare infection control practices advisory C. Management of multidrug-resistant organisms in health care settings, 2006","volume":"35","author":"Siegel","year":"2007","journal-title":"Am J Infect Control"},{"key":"S0899823X25103358_ref20","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.2023.21083","article-title":"Prevalence of Acinetobacter Baumannii and Candida Auris in patients receiving mechanical ventilation","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"S0899823X25103358_ref13","unstructured":"13. Centers for Medicare and Medicaid Services. Cost Reports 2019. https:\/\/www.cms.gov\/data-research\/statistics-trends-and-reports\/cost-reports."},{"key":"S0899823X25103358_ref12","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3201\/eid2007.121004","article-title":"Deaths attributable to carbapenem-resistant Enterobacteriaceae infections","volume":"20","author":"Falagas","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"S0899823X25103358_ref4","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ajic.2020.06.004","article-title":"Shedding of multidrug-resistant gram-negative bacilli by colonized patients during procedures and patient care activities","volume":"48","author":"Alhmidi","year":"2020","journal-title":"Am J Infect Control"},{"key":"S0899823X25103358_ref15","unstructured":"15. Centers for Disease Control and Prevention. MDRO Prevention Strategies, 2022. https:\/\/www.cdc.gov\/healthcare-associated-infections\/php\/preventing-mdros\/mdro-prevention-strategies.html."},{"key":"S0899823X25103358_ref16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/cid\/ciy027","article-title":"Antimicrobial-resistant Klebsiella Pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital","volume":"67","author":"Gorrie","year":"2018","journal-title":"Clin Infect Dis"},{"key":"S0899823X25103358_ref10","unstructured":"10. Centers for Disease Control and Prevention. COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. Atlanta, GA: U.S. Department of Health and Human Services, 2022."},{"key":"S0899823X25103358_ref5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ajic.2012.09.020","article-title":"Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge","volume":"41","author":"Zimmerman","year":"2013","journal-title":"Am J Infect Control"},{"key":"S0899823X25103358_ref21","first-page":"1246","article-title":"The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella Pneumoniae carbapenemase-producing Enterobacteriaceae","volume":"57","author":"Lin","year":"2013","journal-title":"Clin\u00a0Infect Dis"}],"container-title":["Infection Control & Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X25103358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:11:41Z","timestamp":1792055501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X25103358\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0899823X25103358"],"URL":"https:\/\/doi.org\/10.1017\/ice.2025.10335","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"\u00a9 Centers for Disease Control and Prevention, 2026","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}